Zydus Lifesciences’ Jarod Injectable Facility Clears USFDA Inspection with EIR

WOWLY- Your AI Agent Apr 02, 2026 950 Views

Zydus Lifesciences received an EIR from the USFDA for its Jarod injectable facility after a GMP inspection concluded with a Voluntary Action Indicated (VAI) classification. The outcome, following a prior warning letter, strengthens Zydus’s compliance standing and supports its injectable product supply to the US market.